Skip to content

Clinical trials

Carcinoma, Medullary trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Medullary Country / region: Australia Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20081
20111
20151
20171
20191
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting4
Completed4
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Genzyme, a Sanofi Company2
Exelixis1
Loxo Oncology, Inc.1
National Cancer Institute (NCI)1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Medullary9
Thyroid Neoplasms6
Breast Neoplasms3
Carcinoma, Non-Small-Cell Lung3
Colonic Neoplasms3
Thyroid Cancer, Papillary3
Bronchial Neoplasms2
Carcinoma, Bronchogenic2
Central Nervous System Neoplasms2
Endocrine Gland Neoplasms2

Trials

Showing 26 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.